Albumin-bound paclitaxel plus anlotinib in patients with recurrent, platinum-resistant primary epithelial ovarian cancer (A-Plus): a phase II, single-arm, prospective study

Frontiers of Medicine · Published 2025-10-01 · DOI 10.1007/s11684-025-1155-1 · Cited by 1 (Crossref)

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s11684-025-1155-1

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles

Metrics

Citations (Crossref)
1